261 related articles for article (PubMed ID: 24581452)
1. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
Kirkpatrick B
J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
[TBL] [Abstract][Full Text] [Related]
2. Recognizing primary vs secondary negative symptoms and apathy vs expression domains.
Kirkpatrick B
J Clin Psychiatry; 2014 Apr; 75(4):e09. PubMed ID: 24813410
[TBL] [Abstract][Full Text] [Related]
3. [The clinic of apathy in schizophrenia: a critical review of the issue].
Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
[TBL] [Abstract][Full Text] [Related]
4. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
[TBL] [Abstract][Full Text] [Related]
5. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
[TBL] [Abstract][Full Text] [Related]
6. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
Bègue I; Kaiser S; Kirschner M
Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
[TBL] [Abstract][Full Text] [Related]
8. [Negative Symptoms in Schizophrenia - an Overview].
Klaus F; Kaiser S; Kirschner M
Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
[TBL] [Abstract][Full Text] [Related]
9. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
Strauss GP; Gold JM
Schizophr Bull; 2016 Nov; 42(6):1384-1394. PubMed ID: 27174556
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
Neill JC; Harte MK; Haddad PM; Lydall ES; Dwyer DM
Eur Neuropsychopharmacol; 2014 May; 24(5):822-35. PubMed ID: 24287012
[TBL] [Abstract][Full Text] [Related]
11. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.
Ahmed AO; Kirkpatrick B; Galderisi S; Mucci A; Rossi A; Bertolino A; Rocca P; Maj M; Kaiser S; Bischof M; Hartmann-Riemer MN; Kirschner M; Schneider K; Garcia-Portilla MP; Mane A; Bernardo M; Fernandez-Egea E; Jiefeng C; Jing Y; Shuping T; Gold JM; Allen DN; Strauss GP
Schizophr Bull; 2019 Mar; 45(2):305-314. PubMed ID: 29912473
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of the concept of apathy: the need for a multifactorial approach in schizophrenia].
Del-Monte J; Capdevielle D; Gély-Nargeot MC; Yazbek H; Pupier F; Boulenger JP; Raffard S
Encephale; 2013 May; 39 Suppl 1():S57-63. PubMed ID: 23351930
[TBL] [Abstract][Full Text] [Related]
13. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
[TBL] [Abstract][Full Text] [Related]
14. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.
Mueser KT; Sayers SL; Schooler NR; Mance RM; Haas GL
Am J Psychiatry; 1994 Oct; 151(10):1453-62. PubMed ID: 7916540
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Brief Negative Symptom Scale and its association with functioning.
Ang MS; Rekhi G; Lee J
Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
[TBL] [Abstract][Full Text] [Related]
16. Negative symptoms of schizophrenia: new developments and unanswered research questions.
Galderisi S; Mucci A; Buchanan RW; Arango C
Lancet Psychiatry; 2018 Aug; 5(8):664-677. PubMed ID: 29602739
[TBL] [Abstract][Full Text] [Related]
17. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
Nkam I; Langlois-Thery S; Dollfus S; Petit M
Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
[TBL] [Abstract][Full Text] [Related]
18. Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
Strauss GP; Vertinski M; Vogel SJ; Ringdahl EN; Allen DN
Schizophr Res; 2016 Feb; 170(2-3):285-9. PubMed ID: 26742510
[TBL] [Abstract][Full Text] [Related]
19. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
[TBL] [Abstract][Full Text] [Related]
20. Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample.
Simon JJ; Zimmermann J; Cordeiro SA; Marée I; Gard DE; Friederich HC; Weisbrod M; Kaiser S
Psychiatry Res; 2018 Feb; 260():138-143. PubMed ID: 29195165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
